Case Study: Hepalink Pharmaceutical ensures global regulatory submission compliance with EXTEDO eCTDmanager

Hepalink Pharmaceutical streamlines global regulatory submissions with EXTEDO

Hepalink Pharmaceutical, a leading Chinese bio-pharmaceutical company, needed a solution to ensure compliance with global electronic submission requirements from authorities like the FDA and EMA to continue marketing its products worldwide. To address this challenge, Hepalink partnered with EXTEDO to redefine its process for handling regulatory dossiers using the eCTDmanager solution.

EXTEDO implemented its eCTDmanager product to help Hepalink manage its regulatory submissions effectively. While the provided text does not list specific measurable results, the solution enabled the company to meet the mandatory global requirements for electronic submissions, ensuring its products could remain on the international market.

Hepalink Pharmaceutical